Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

RA Capital Nexus Fund III, L.P. bought 6,510,416 Artiva Biotherapeutics, Inc. shares (Form 4)

Traded May 11, 2026 · Filed May 13, 2026

On May 11, 2026, RA Capital Nexus Fund III, L.P. (Director) bought 6,510,416 Artiva Biotherapeutics, Inc. shares at US$11.52 for US$75M, leaving 15,203,995 shares. Filed May 13, 2026 (Form 4).

Bought
6,510,416 shares
Price
US$11.52
Value
US$75M
Holding after
15,203,995 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 11, 2026Common StockBuy6,510,416US$11.5215,203,995Indirect

Source

View original at SEC

Related